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Abstract
Background: Peripherin, a type III neuronal intermediate filament, is widely expressed in neurons of the
peripheral nervous system and in selected central nervous system hindbrain areas with projections towards
peripheral structures, such as cranial nerves and spinal cord neurons. Peripherin appears to play a role in neurite
elongation during development and axonal regeneration, but its exact function is not known. We noticed high
peripherin expression in the posterior hypothalamus of mice, and decided to investigate further the exact location
of expression and function of peripherin in the mouse posterior hypothalamus.
Results: In situ hybridization indicated expression of peripherin in neurons with a distribution reminiscent of the
histaminergic neurons, with little signal in any other part of the forebrain. Immunocytochemical staining for
histidine decarboxylase and peripherin revealed extensive colocalization, showing that peripherin is produced by
histaminergic neurons in all parts of the tuberomammillary nucleus. We next used histamine immunostaining in
peripherin knockout, overexpressing and wild type mice to study if altered peripherin expression affects these
neurons, but could not detect any visible difference in the appearance of these neurons or their axons.
Peripherin knockout mice and heterozygotic littermates were used for measurement of locomotor activity,
feeding, drinking, and energy expenditure. Both genotypes displayed diurnal rhythms with all the parameters
higher during the dark period. The respiratory quotient, an indicator of the type of substrate being utilized, also
exhibited a significant diurnal rhythm in both genotypes. The diurnal patterns and the average values of all the
recorded parameters for 24 h, daytime and night time were not significantly different between the genotypes,
however.
Conclusion: In conclusion, we have shown that peripherin is expressed in the tuberomammillary neurons of the
mouse hypothalamus. Monitoring of locomotor activity, feeding, drinking, and energy expenditure in mice either
lacking or overexpressing peripherin did not reveal any difference, so the significance of peripherin in these
neurons remains to be determined. The complete overlap between histidine decarboxylase and peripherin, both
the protein and its mRNA, renders peripherin a useful new marker for histaminergic neurons in the hypothalamus.
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Peripherin, a type III neuronal intermediate filament pro-
tein, is widely expressed in neurons of the peripheral nerv-
ous system (PNS). It is also expressed in a restricted set of
brain stem and spinal cord neurons that usually project
towards peripheral structures. Most notably, expression of
peripherin was demonstrated in several motor nuclei of
cranial nerves, ventral horn motor neurons and in the
cholinergic laterodorsal tegmentum (LDT) and peduncu-
lopontine tegmentum (PPT) nuclei. In addition, a few
unidentified neurons of the posterior hypothalamus con-
tained peripherin, whereas it was absent from the major
monoaminergic nuclei of the brainstem and midbrain [1-
3].
Peripherin can self-assemble or co-assemble with other
neurofilament subunits to form intermediate filament
networks [4]. Developmental expression peaks during the
axonal growth phase and decreases postnatally [5], sug-
gesting a role in neurite elongation during development.
The expression of peripherin is also upregulated after neu-
ronal injury e.g. in motor neurons and dorsal root ganglia
after peripheral axotomy, supporting a role for this pro-
tein in axonal regrowth [6,7]. It should be noted, how-
ever, that in spite of the fact a majority of spinal cord
motoneurons express peripherin, peripherin knockout
(KO) mice exhibit no overt phenotype, develop, survive
and reproduce normally. Motoneuron morphology, neu-
rite outgrowth and axonal path finding also appear nor-
mal in these mice, although a subset of small
unmyelinated sensory fibers are lost. This may be
explained by redundancy and the presence of type IV
intermediate neurofilaments in many neurons. The exact
function of peripherin is thus not known [8].
Overexpression of peripherin interferes with anterograde
axonal transport. As a result, neurofilament aggregates
form in neuronal somata and axons, ultimately producing
spinal motor neuron death in overexpressing transgenic
mice [9,10]. Such an accumulation of peripherin-contain-
ing neurofilaments has also been demonstrated in degen-
erating spinal motor neurons of amyotrophic lateral
sclerosis patients and in the murine model of this disease,
i.e., the transgenic mice expressing a mutant of the super-
oxide dismutase-1 (SOD1G37R), a motor neuron disease
characterized by loss of motor neurons resulting in paral-
ysis and death [11-13].
Peripherin may also be involved in the pathology of insu-
lin-dependent diabetes mellitus (IDDM). Indeed, the pro-
tein is a known target autoantigen in the nonobese
diabetic mouse model, where islet cell infiltrating B-cell
clones reactive to peripherin have been identified early in
the course of the disease. Peripherin is produced by both
the PNS and, in young animals, by islet β cells, so it is con-
ceivable that this immune response is involved in the
destruction of both PNS elements and islet β cells in
IDDM, although no direct involvement of this antigen has
yet been shown in human patients [14].
During a microarray experiment comparing the gene
expression of the posterior hypothalamus with that of the
lateral hypothalamus in mice, we found a sixty-fold
higher expression of peripherin in the posterior hypotha-
lamus. We therefore have used in situ hybridization (ISH),
immunocytochemistry (ICC) and in vivo recordings in
mice overexpressing peripherin [9], peripherin KO mice
[8] and their littermates to study the expression and func-
tion of peripherin in the posterior hypothalamus. We
report that peripherin is expressed by the histaminergic
tuberomammillary (TM) neurons of the posterior hypoth-




ISH with a 35S-labelled probe indicated expression of
peripherin in the posterior hypothalamus (Fig 1A). Stain-
ing with a digoxigenin labelled probe demonstrated a dis-
tribution of the peripherin signal in neurons with a
distribution reminiscent of the histaminergic neurons (Fig
1B). Double ISH staining with a digoxigenin labelled
peripherin probe and a 35S-labelled probe for the hista-
mine-synthesizing enzyme histidine decarboxylase
(HDC) indicated colocalization, showing that peripherin
is expressed in the histaminergic TM neurons (Fig 1C). We
did not detect reliable expression of peripherin in any
other part of the forebrain. Peripherin mRNA signal was
absent in peripherin KO mice.
Double ICC staining for HDC and peripherin revealed
extensive colocalization, showing that peripherin immu-
noreactivity is located in histamine-producing neurons
across the entire TM nucleus (Fig 2). Almost all (> 95%)
TM neurons were stained for both proteins, although sin-
gle neurons stained for only one of the proteins were occa-
sionally seen. This lack of staining was usually seen when
the general staining for the antigen was weak and may
thus have been caused by low sensitivity. Neurons that
stained only for peripherin were only occasionally seen in
this part of the brain.
Histamine ICC was used to study whether altered
peripherin expression would affect TM neurons and their
processes. After histamine ICC, comparisons between
peripherin KO, overexpressing and WT mice did not
reveal any visible difference in the appearance of TM neu-
rons or in the density of histamine immunoreactive axons
in any of the studied brain regions.Page 2 of 9
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energy expenditure in peripherin KO animals
Central histamine has been implicated in the regulation
of sleep-wake regulation, cognition, metabolism, and
appetite regulation. Three months old female and male
heterozygotic (Hz) and homozygotic (H) littermates were
introduced to the recording chambers at Zeitgeber time
(ZT) 10 (i.e., two hours before lights-off). There was no
significant difference in body weight between the Hz and
H mice (Table 1). Upon entering the chambers, all mice
displayed a brief period of exploratory behaviour and the
level of locomotor activity (LMA) gradually returned to
daytime baseline after 1 hour. This adaptation period was
similar between both genotypes (data not shown). Both
genotypes displayed diurnal rhythms in LMA, drinking,
feeding and energy expenditure with all the parameters
higher during the dark period and lower during the light
period. The respiratory quotient (RQ), an indicator of the
type of substrate being utilized, also exhibited a signifi-
cant diurnal rhythm in both genotypes. During the day,
when mice are mostly resting and not feeding, the RQ was
lower, indicating a higher fat utilization. The diurnal pat-
terns and the average values of all the parameters for 24 h,
daytime and nighttime were not significantly different
between the genotypes (Table 1). Two-way ANOVA
revealed significant differences in LMA, drinking and
energy expenditure (EE) between sexes, whereas no inter-
action between sex and genotype was found.
As the other physiological parameters didn't suggest any
major behavioral differences, and due to a lack of suffi-
cient numbers of animals, sleep was not directly accessed
in these animals. As a proxy, we measured LMA at 1 min
interval and studied the distribution of active (wake) and
inactive (sleep and quiet wake) bouts during the day and
night [15]. This algorithm was tested in hypocretin-ataxin
mice that display significant sleep/wake fragmentation
compared to wild type (WT) littermates. As these mice
were included solely to validate the algorithm, we decided
that it was sufficient to only test it on female mice. As
expected the active/inactive state distribution was signifi-
cantly shifted to shorter active and inactive periods.
According to this algorithm, each minute with an activity
level of more than 6 counts is considered as active state,
and the rest is quiet states. The duration and number of
each continuous state is then calculated, a distribution
plotted (Fig. 3) and subjected to statistical analysis. In
comparing narcoleptic and control mice, we found that
episodes of short duration (< 20 min) were significantly
more frequent in ataxin-hypocretin transgenic (TG) than
in WT mice (150.3 ± 6.3 vs. 118.6 ± 11.9, p = 0.035, n = 8
each) while active episodes of long, consolidated, dura-
tion (> 40 min) were less frequent in TG than in WT mice
(1.8 ± 0.6 vs. 4.5 ± 0.7, p = 0.011.05, n = 8 each). Con-
versely, inactive episodes of short duration (< 5 min) were
significantly less frequent than in WT mice (124.3 ± 6.4 vs.
88.3 ± 12.8, p = 0.025, n = 8 each). These results validated
the use of activity bout measurements as a partial proxy
for the study of sleep, as these results closely mimics
sleep/wake distribution abnormalities in these mice based
on traditional sleep recording [15]. In contrast to the
results obtained above, when we compared histograms
and means for the peripherin KO Hz and H mice, we
could not detect any significant difference in LMA or any
of the other recorded parameters (Fig. 3).
In situ hybridization of peripherinFigure 1
In situ hybridization of peripherin. The expression of peripherin mRNA was studied with ISH. The autoradiogram in A 
shows a mouse brain section hybridized with a 35S-labelled peripherin probe. The selective staining of the TM nucleus is evi-
dent. In B, a digoxigenin labelled mRNA probe reveals the distribution of peripherin expressing neurons in detail. The distribu-
tion is very similar to the histaminergic TM neurons. In C, neurons of the lateral TM that were hybridized simultaneously with 
a digoxigenin labelled probe for peripherin and a 35S-labelled probe for HDC are shown. The alkaline phosphatase staining for 
peripherin, which differentiate the neurons from the background, is colocalized with the silver grains that indicate the localiza-
tion of HDC expression. 3 V, third ventricle. Scale bar 100 μm in B, 20 μm in C.Page 3 of 9
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In this study we have shown that histaminergic TM neu-
rons produce peripherin, a neurofilament mainly
expressed in neurons with long axonal projections to the
periphery. TM neurons send out axons that innervate
most parts of the brain and, at a lower density, the spinal
cord [16,17]; innervation of peripheral targets by these
neurons has never been described. Expression of
peripherin in TM neurons suggested that these neurons
may need this protein for elongation or projection path-
finding. To test this hypothesis, we used immunostaining
to study histaminergic axons in the brain of peripherin
KO and over-expressing mice, but we could not observe
any difference in the distal innervation in any of the stud-
ied regions. This negative result is in agreement with the
findings of Larivière and co-workers [8], who studied the
KO mice and, apart from the absence of a subset of spinal
sensory axons, found no morphological abnormalities in
these animals.
TM neurons have been implicated in the regulation of
waking and feeding behaviours [18], and their activity is
strongly associated with behavioural state; they fire toni-
cally in a regular pattern during waking but not at all dur-
ing deep slow wave sleep and rapid eye-movement sleep
[19]. Inhibition of histamine release or treatment with
histamine H1 receptor antagonists lead to an increase in
cortical slow activity and increased sleep, whereas
increased histamine signalling induces cortical desyn-
chronization and decreases sleep [20-23]. Furthermore,
mice lacking either HDC or the H1 receptor are incapable
of prolonged activity and wakefulness, most notably in a
novel environment, and also have a disturbed circadian
rhythm of locomotor activity [24,25]. There is also evi-
dence that histamine is involved in the control of feeding.
Indeed, increased CNS histamine concentration decreases
feeding in rats, whereas feeding is increased by H1 receptor
antagonists or by inhibition of histamine synthesis
[26,27].
Larivière and co-workers [8] did not observe any obvious
phenotype in peripherin KO mice. They did not measure
activity level, however, so to further explore the possibility
of a behavioural phenotype in these mice, we studied the
circadian pattern in LMA, energy expenditure, feeding and
drinking. We could not detect any significant difference
between peripherin KO mice and controls, however, so
the function of peripherin in the TM and other neurons
that could influence such behaviors will need more study.
Earlier studies suggest a role for peripherin in axonal elon-
gation and repair, and there is also some evidence for a
role in hippocampal synaptic plasticity [28], and transient
events, such as axonal rewiring or synaptic reorganization,
which also could be expected to cause rather subtle
changes, could have gone undetected in our study. It is
also possible that we would have found a difference
between KO and control mice if we had used some type of
behavioral or pharmacological challenge or sleep depriva-
tion.
It was recently demonstrated that many islet-infiltrating B-
cells in IDDM produce antibodies that are specific for
peripherin and therefore recognize the PNS, which could
explain the neuropathy that is commonly seen in IDDM
[14]. Another protein that is produced by islet β-cells as
Immunostaining of HDC and peripherinFigure 2
Immunostaining of HDC and peripherin. We pre-
formed double immunocytochemistry for HDC and 
peripherin. There is an extensive colocalization of the two 
proteins in the TM neurons. In A, the ventral/lateral part of 
the TM nucleus is stained for HDC in red. In B the same area 
is stained for peripherin (green). The staining for the two 
proteins is digitally merged in C. Neurons that are stained for 
both HDC and peripherin appear yellow in this picture. Most 
neurons are stained for both antigens. Scale bar 20 μm.Page 4 of 9
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(GAD), is an important autoantigen in both IDDM and
stiff-man syndrome, an uncommon CNS disorder caused
by impaired GABAergic neurotransmission that often
coexist with IDDM [29,30]. It is not known whether
peripherin autoimmunity may cause damage to the PNS
or CNS, but if the autoimmune mechanisms directed
towards peripherin leads to attacks on CNS neurons in the
same manner as GAD-specific antibodies target GABAer-
gic neurons, the TM neurons could be especially suscepti-
ble, as they in addition to peripherin also express GAD
[31].
The expression of peripherin in the brain stem and spinal
cord is largely restricted to cholinergic neurons. Thus,
peripherin immunoreactive neurons include autonomic
motor neurons, preganglionic sympathetic neurons, neu-
rons in the PPT and LDT, as well as brain stem and spinal
cord motor nuclei [1]. This, together with the recent find-
ing that the TM neurons express a peripheral splice variant
choline acetyl transferase, [32] hint at the possibility that
the expression of peripherin is somehow linked to cholin-
ergic neurotransmission.
For the double ICC stainings we needed a marker that
stains all TM neurons selectively. There are several mark-
ers for these neurons available. Antiserum against hista-
mine stains these neurons very well [16], but the best
antiserum available needs a special fixative (see methods),
which is incompatible with some antigens and, as we
found out, this includes peripherin. The TM neurons also
contain GAD and GABA. Antisera against these two com-
pounds tend to be difficult to use and are not selective for
the TM neurons, as there are other GABAergic neurons
close to the TM nucleus. Antisera against adenosine deam-
inase stain TM neurons in the rat [33], but to our knowl-
edge this has not been reported from any other species,
and in our experience these antisera don't stain mouse TM
neurons at all. There are several neuropeptides present in
the TM neurons, but there is considerable interspecies var-
iation and antisera against these peptides tend to only
stain a fraction of the TM neurons [31]. In the light of the
above, HDC, and possibly GAD or GABA, were the only
markers we could think of that would stain all the TM
neurons in formalin-fixed mouse tissue. Therefore, we
think that peripherin will be a useful addition to the rep-
ertoire of markers for TM neurons, as it is highly specific
for these neurons in the hypothalamus.
Conclusion
In conclusion, we have shown that peripherin is expressed
in the TM neurons of the mouse hypothalamus. We could
not detect any neuroanatomical or behavioural pheno-
type in mice either lacking or overexpressing peripherin,
so the significance of peripherin in TM neurons remains
to be determined. The complete overlap between HDC
and peripherin, both the protein and its mRNA, makes it
a useful new marker for TM neurons.
Table 1: Parameters of peripherin KO mice measured in metabolic chambers (Mean ± SEM)
Female H (n = 6) Female Hz (n = 6) Male H (n = 5) Male Hz (n = 5)
Body weight (g)
24.1 ± 0.8 23.7 ± 1.1 32 ± 1 30.5 ± 0.5
LMA (count/h)
Day 1922 ± 161 1734 ± 174 1289 ± 182 1135 ± 129
Night 5102 ± 725 4764 ± 476 3010 ± 536 2278 ± 196
24 h 3512 ± 415 3249 ± 307 2150 ± 353 1707 ± 150
Food intake (g)
Day 1.6 ± 0.1 1.1 ± 0.2 1.2 ± 0.2 1.2 ± 0.1
Night 3.1 ± 0.2 3.1 ± 0.4 2.7 ± 0.2 2.6 ± 0.3
24 h 4.7 ± 0.3 4.2 ± 0.4 3.8 ± 0.3 3.8 ± 0.3
Water intake (mL)
Day 1.4 ± 0.1 1.6 ± 0.2 1.0 ± 0.1 0.7 ± 0.2
Night 3.8 ± 0.6 4.3 ± 0.6 2.2 ± 0.2 2.1 ± 0.3
24 h 5.2 ± 0.7 5.9 ± 0.8 3.3 ± 0.3 2.8 ± 0.4
EE (kcal/h)
Day 0.75 ± 0.05 0.72 ± 0.02 0.53 ± 0.01 0.52 ± 0.03
Night 0.89 ± 0.05 0.87 ± 0.03 0.58 ± 0.02 0.58 ± 0.02
24 h 0.82 ± 0.05 0.79 ± 0.02 0.56 ± 0.01 0.55 ± 0.02Page 5 of 9
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Mice and tissue preparation
Experiments were performed using peripherin KO mice of
mixed 129/C57Bl/6 background that have a targeted dis-
ruption of the peripherin gene [8], peripherin overex-
pressing TG mice of C57Bl/6 genetic background carrying
20 copies of the peripherin gene [9] and their WT litterma-
tes. Ordinary C57BL/6J mice were used in some double
stainings due to a shortage of littermates. Three female
10–15 weeks-old mice of each genotype were given an
overdose of pentobarbital and perfused transcardially
with either 10% neutral buffered formalin or, for hista-
mine ICC, wit h 4% 1-ethyl-3(3-dimethyl-aminopropyl)-
carbodiimide and 0.2% N-hydroxysuccinimide (Sigma-
Aldrich, St. Louis, MO) in 0.1 M phosphate buffer, pH 7.4.
Brains were removed and immersed in the same fixative
over night, cryoprotected, and cryosectioned at 15–25 μm
thickness.
Hypocretin-ataxin TG mice (N8 and beyond, thus consid-
ered pure C57Bl/6) expressing a truncated Machado-
Joseph disease gene product (ataxin-3) with an expanded
polyglutamine stretch specifically in hypocretin neurons
[34] were used to develop the algorithm for predicting
sleep/wake pattern based on LMA data measured. The
expression of ataxin-3 in hypocretin-expressing neurons
causes cell death, and the transgenic mice display signifi-
cant sleep/wake fragmentation compared to their wild
Measurement of locomotor activityFigure 3
Measurement of locomotor activity. Histograms of active (top) and quiet (bottom) bout duration in peripherin heterozy-
gotic (Hz) and homozygotic (H) mice. Locomotor activity data were collected at 1 minute intervals. Each minute with LMA 
larger than 6 counts was defined as being active, and the rest were defined as being quiet. A bout was defined as a period dur-
ing which a state presented consecutively without interruption of the other. For equal bin histograms (left), the active bout 
data are binned in 4-minute intervals, and the quiet bout data are binned in 1-minute intervals. The solid lines with white circles 
represent group averages of the Hz mice and the solid lines with black circles represent group averages of the H mice. The bar 
graphs (right) show the differences between the Hz and H mice in three arbitrary bins of bout duration. The white bars repre-
sent the Hz mice and the black bars represent the H mice. A similar analysis of LMA in 8 hypocretin-ataxin mice versus 8 con-
trol littermates was effective in predicting sleep/wake fragmentation hypocretin-ataxin mice (see text).Page 6 of 9
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months and 8 WT female littermates were used for this
study.
All efforts were made to minimize animal suffering and to
reduce the number of animals used. The study was
approved and conducted in accordance with the guide-
lines of Stanford's Administrative Panel for Laboratory
Animal Care.
In situ hybridization
Cloned cDNAs corresponding to the complete coding
sequence of the mouse peripherin mRNA (IMAGE clone
ID 6475506, [Genbank:BC046291]) and HDC mRNA
(IMAGE clone ID 5361831, [Genbank: BI732768] were
purchased from Invitrogen; inserts were sequence verified.
After purification using the Qiaprep Miniprep Kit (Qia-
gen), plasmids were linearized with EcoRI and transcribed
with T7 polymerase using the Riboprobe System
(Promega, Madison, WI) and 35S-UTP (Amersham/GE
Healthcare Bio-Sciences, Piscataway, NJ) or digoxigenin-
UTP (Roche Diagnostics, Indianapolis, IN) to produce
antisense riboprobes.
Probes were diluted in hybridization buffer comprising of
600 mM NaCl, 10 mM Tris-HCl (pH 7.5), 1 mM EDTA
10% dextran sulphate, salmon sperm DNA 0.01%, yeast
RNA 0.005, 1× Denhardt's solution, 0.01% SDS, 0.01%
sodium thiosulphate, 100 mM DTT (all reagents from
Sigma) and 50% formamide (Fischer Scientific, Pitts-
burgh, PA). Radiolabeled riboprobes were diluted to give
3 × 104 counts/μl, whereas digoxigenin-labelled probes
were diluted 1:500. Sections were pretreated for 10 min in
citrate buffer (pH 6.0) at ~95°C, and hybridized for
12–16 hr at 54°C. After RNase A (20 μg/ml; Sigma) treat-
ment for 30 min at 37°C, the tissue was washed in 2×SSC
at 50°C for 1 hour, in 0.2×SSC at 55°C for 1 hour and in
0.2×SSC at 65°C for 1 hour. After dehydration, slides with
35S probes were exposed to X-ray films for 1 to 40 days,
whereas slides hybridized with digoxigenin probes were
immunostained. For immunostaining, slides were treated
with 3% normal sheep serum and 0.1% Triton X-100 in
phosphate-buffered saline (pH 7.3; PBS) for 3 hours, fol-
lowed by overnight incubation in alkaline phosphatase-
conjugated sheep anti-digoxigenin antibodies (1:5000
dilution; Roche). After blocking of endogenous alkaline
phosphatase in 0.1% levamisole for 5 min, blue-purple
reaction products were visualized by incubation in 0.3
mg/ml nitro blue tetrazolium and 0.2 mg/ml 5-bromo-4-
chloro-3-indolyl phosphate (Roche) in GB3 buffer (pH
9.5) at RT for 12–36 hours. Some slides were hybridized
with both a 35S-labelled and a digoxigenin-labelled probe.
After alkaline phosphatase staining, these slides were first
covered with parlodione and then dipped in liquid NTB2
emulsion (Kodak, Rochester, NY) and exposed in dark-
ness for 3–6 weeks.
Immunocytochemistry
Antibody incubations and washes were done at room
temperature in PBS with 0.25% Triton X-100. Antibody
solutions all contained 2% donkey serum. The tissue was
treated with 1% H2O2 for 15 min to quench endogenous
peroxidase, blocked with 5% normal donkey serum for
2–4 hours and incubated overnight with primary antise-
rum. Double staining for HDC and peripherin was done
in sequence. The first staining was done using guinea pig-
anti-HDC serum (1:200 overnight; American Research
Products, Belmont, MA), biotinylated donkey-anti-guinea
pig (1:500 for 90 min; Jackson Immunoresearch, West
Grove, PA), avidin-biotin complex (1:500 for 90 min;
Vector Laboratories, Burlingame, CA), biotinylated tyra-
mide (1:50 for 10 min; Perkin Elmer, Boston, MA) and
Alexa Flour 555-conjugated streptavidin (1:500 for 90
min; Molecular Probes, Eugene, OR). After HDC staining,
tissue was treated with 1 H2O2 for 45 min and the avidin-
biotin blocking kit (Vector) to prevent interference with
the second staining. The tissue was then incubated with
rabbit-anti-peripherin (1:3000 overnight; Chemicon,
Temecula, CA), biotinylated donkey-anti-rabbit (1:500
for 90 min; Jackson), avidin-biotin complex (1:500 for 90
min), biotinylated tyramide (1:50 for 10 min) and Alexa
Fluor 488-conjugated streptavidin (1:200 for 90 min;
Molecular Probes). Single stainings of each protein were
done to verify results. Stainings where either primary
antiserum were excluded were also done to examine the
possibility of cross-reactions. For histamine a rabbit-anti-
histamine serum (1:500; Chemicon) was used. After
washing, slides were incubated with Alexa Fluor 488-con-
jugated donkey-anti-rabbit serum (Molecular Probes). All
steps were performed at RT and slides were washed for at
least 20 min after each step. Finally, micrographs of the
alkaline phosphate staining for mRNA and fluorescence
stainings were taken with a microscope equipped with a
digital camera.
Measurement of locomotor activity, feeding, drinking, and 
energy expenditure
Mice (for peripherin KO line, 6 Hz females, 6 H females,
5 Hz males, 5 H males, age 3–4 months; for hypocretin-
ataxin transgenic line, 8 WT females, 8 TG females, age 7
month old) were introduced to an 11 × 31 × 12 cm Plex-
iglas recording chamber for indirect calorimetric measure-
ment of oxygen consumption and carbon dioxide
production (Oxymax, Columbus Instruments, Columbus,
OH). Room air was supplied to the chamber at a flow rate
of 570 ml/min, and was referenced every hour during
measurement. Each chamber was equipped with real-time
monitoring of powdered food intake, cyclic measure-
ments of water intake through volumetric detectors and ofPage 7 of 9
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simultaneous measurement of 16 animals at a time with
indirect calorimetric measurements cycling through the
chambers once every hour, measuring one chamber at a
time. Mice spent at least 48 hours adapting to the environ-
ment; data collected after this adaptation period were
used in the analyses. Bodyweight was measured before
and after each experiment to ensure animal health.
Feeding, drinking, and energy expenditure data were all
adjusted for a body weight of 30 g. Energy expenditure
was calculated from measured oxygen consumption
(VO2) and carbon dioxide production (VCO2): EE = 3.815
× VO2 + 1.232 × VCO2. Respiratory quotient was defined
as: RQ = VCO2/VO2. Data were analyzed with Student's t-
test and two-way ANOVA.
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